Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration. The company also develops NB1, a NELL-1/DBM fusion device for use in lumbar spinal fusion, as well as spine implants, non-union trauma cases, and osteoporosis applications. It serves spine surgeons and patients with a skeletal bone defect or bone-related condition in their spine. The company has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion by local administration, osteoporosis, and trauma applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
Frequently asked questions
What sector does Bone Biologics Corp (BBLG) operate in?
Bone Biologics Corp belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Bone Biologics Corp (BBLG) current stock price?
As of the latest data, Bone Biologics Corp stock price is $0.66, with a previous close of $0.67. Bone Biologics Corp lost -$0.02 in the last trading session, representing a -2.86% loss.
What is Bone Biologics Corp (BBLG) current market capitalization?
Bone Biologics Corp market cap is approximately 1.19 million.
What is Bone Biologics Corp (BBLG) Earnings Per Share (EPS)?
The trailing EPS is -$1.16, and the forward EPS is -$0.64.
What is Bone Biologics Corp (BBLG) EBITDA?
Bone Biologics Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -765.99 thousand.
Does Bone Biologics Corp (BBLG) pay dividends?
No. Bone Biologics Corp does not pay a dividend.
When is Bone Biologics Corp (BBLG) next earnings report?
Bone Biologics Corp is expected to release its next earnings report on June 30, 2026.
What is Bone Biologics Corp (BBLG) beta (volatility) score?
Bone Biologics Corp has a beta of 0.530, indicating lower volatility than the overall market.
